IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9.

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • HH Erb - , Innsbruck Medical University (Author)
  • RV Langlechner - (Author)
  • PL Moser - (Author)
  • F Handle - (Author)
  • T Casneuf - (Author)
  • K Verstraeten - (Author)
  • B Schlick - (Author)
  • G Schäfer - (Author)
  • B Hall - (Author)
  • K Sasser - (Author)
  • Z Culig - (Author)
  • FR Santer - (Author)

Details

Original languageEnglish
JournalEndocrine-related cancer
Publication statusPublished - Oct 2013
Peer-reviewedYes
Externally publishedYes

External IDs

PubMed 23913484
PubMed PMC3753051
Scopus 84886428517

Keywords

Sustainable Development Goals